These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25296874)

  • 41. Cortical pathology and cognitive impairment in multiple sclerosis.
    Calabrese M; Rinaldi F; Grossi P; Gallo P
    Expert Rev Neurother; 2011 Mar; 11(3):425-32. PubMed ID: 21375447
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relative contributions of processing speed and cognitive load to working memory accuracy in multiple sclerosis.
    Leavitt VM; Lengenfelder J; Moore NB; Chiaravalloti ND; DeLuca J
    J Clin Exp Neuropsychol; 2011 Jun; 33(5):580-6. PubMed ID: 21229437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
    Yaldizli Ö; Penner IK; Frontzek K; Naegelin Y; Amann M; Papadopoulou A; Sprenger T; Kuhle J; Calabrese P; Radü EW; Kappos L; Gass A
    Mult Scler; 2014 Mar; 20(3):356-64. PubMed ID: 23959709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive functioning in multiple sclerosis.
    Julian LJ
    Neurol Clin; 2011 May; 29(2):507-25. PubMed ID: 21439456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients.
    Covey TJ; Shucard JL; Shucard DW; Stegen S; Benedict RH
    J Int Neuropsychol Soc; 2012 May; 18(3):530-40. PubMed ID: 22410107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
    Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MRI correlates of cognitive dysfunction in multiple sclerosis patients.
    Rovaris M; Filippi M
    J Neurovirol; 2000 May; 6 Suppl 2():S172-5. PubMed ID: 10871808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cognitive dysfunction in multiple sclerosis: the effect of pharmacological interventions.
    Lyros E; Messinis L; Papageorgiou SG; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):35-42. PubMed ID: 20222786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
    Guenter W; Jabłońska J; Bieliński M; Borkowska A
    Psychiatr Pol; 2015; 49(5):897-910. PubMed ID: 26688841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive reserve in multiple sclerosis.
    Sumowski JF; Leavitt VM
    Mult Scler; 2013 Aug; 19(9):1122-7. PubMed ID: 23897894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
    Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies.
    Amato MP; Zipoli V; Portaccio E
    J Neurol Sci; 2006 Jun; 245(1-2):41-6. PubMed ID: 16643953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.
    Penner IK; Kappos L; Rausch M; Opwis K; Radü EW
    J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
    Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
    Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Correlation between demyelinating lesions and executive function decline in a sample of Mexican patients with multiple sclerosis].
    Aldrete Cortez VR; Duriez-Sotelo E; Carrillo-Mora P; Pérez-Zuno JA
    Neurologia; 2013 Sep; 28(7):394-9. PubMed ID: 23260448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
    Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
    Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in cognitive performance over a 1-year period in children and adolescents with multiple sclerosis.
    Till C; Racine N; Araujo D; Narayanan S; Collins DL; Aubert-Broche B; Arnold DL; Banwell B
    Neuropsychology; 2013 Mar; 27(2):210-9. PubMed ID: 23527649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
    Bergendal G; Fredrikson S; Almkvist O
    Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Depression in multiple sclerosis].
    Lebrun C; Cohen M
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S156-62. PubMed ID: 19361681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.